There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for Doximity Inc (DOCS) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.11, or 0.46%, to $23.99. The Doximity Inc has recorded 109,210 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Doximity Announces Fiscal 2024 Second Quarter Financial Results.
This NYSE-listed company operates within the Health Information Services industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $23.88 and fluctuated between $24.49 as its day high and $23.81 as its day low. The current market capitalization of Doximity Inc is $4.62B. A total of 3.62 million shares were traded on the day, compared to an average of 2.25M shares.
Insider trades can also provide insight into a stock’s future direction. During the recent three months, DOCS has seen 2 BUY and 3 SELL insider trades, representing the acquisition of 1,481,000 and the disposition of 1,448,955 shares. Over the last 12 months, there were 20 BUYs and 19 SELLs from insiders. Insiders purchased 7,491,260 shares during that period but sold 7,326,268.
In the most recent transaction, Overpeck Craig sold 1,000 shares of DOCS for 21.55 per share on Oct 16. After the transaction, the insider now owns 119,741 company shares. In a previous transaction on Sep 15, Overpeck Craig sold 1,000 shares at 21.48 per share. DOCS shares that the insider owns now total 120,741.
Among the insiders who sold shares, Cabral Timothy S disposed of 4,714 shares on Jul 28 at a per-share price of $34.96. This resulted in the Director holding 10,258 shares of DOCS after the transaction. In another insider transaction, Cabral Timothy S sold 7,500 shares at $35.00 per share on Jul 12. Company shares held by the Director now total 4,714.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for DOCS in the last 3 months, the mean price target is $26.27 with high estimates of $31.00 and low estimates of $21.00. In terms of 52-week highs and lows, DOCS has a high of $40.12 and a low of $19.71.
As of this writing, DOCS has an earnings estimate of $0.23 per share for the current quarter. EPS was calculated based on a consensus of 10 estimates, with a high estimate of $0.25 per share and a lower estimate of $0.21. The company reported an EPS of $0.19 in the last quarter, which was 26.70% higher than expectations of $0.15.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. DOCS’s latest balance sheet shows that the firm has $798.11M in Cash & Short Term Investments as of fiscal 2022. There were $1.09M in debt and $111.28M in liabilities at the time. Its Book Value Per Share was $4.62, while its Total Shareholder’s Equity was $878.59M.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DOCS is Buy with a score of 3.13.